Lifeward (LFWD) Revenue (QoQ) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Lifeward | 5.59 Mn | -5.81 Mn | 1.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -22.79% |
| Dec 31, 2025 | -17.98% |
| Sep 30, 2025 | 8.23% |
| Jun 30, 2025 | 13.71% |
| Mar 31, 2025 | -33.28% |
| Dec 31, 2024 | 23.12% |
| Sep 30, 2024 | -8.63% |
| Jun 30, 2024 | 26.95% |
| Mar 31, 2024 | -23.26% |
| Dec 31, 2023 | 56.35% |
| Sep 30, 2023 | 229.32% |
| Jun 30, 2023 | 8.70% |
| Mar 31, 2023 | -43.55% |
| Dec 31, 2022 | 145.94% |
| Sep 30, 2022 | -43.57% |
| Jun 30, 2022 | 79.22% |
| Mar 31, 2022 | -29.47% |
| Dec 31, 2021 | -37.02% |
| Sep 30, 2021 | 37.33% |
| Jun 30, 2021 | 9.12% |
| Mar 31, 2021 | 8.05% |
| Dec 31, 2020 | 63.05% |
| Sep 30, 2020 | -55.22% |
| Jun 30, 2020 | 119.47% |
| Mar 31, 2020 | -35.65% |
| Dec 31, 2019 | -4.29% |
| Sep 30, 2019 | 40.71% |
| Jun 30, 2019 | -44.53% |
| Mar 31, 2019 | 0.13% |
| Dec 31, 2018 | -2.35% |
| Sep 30, 2018 | -8.64% |
| Jun 30, 2018 | 12.10% |
| Mar 31, 2018 | 4.22% |
| Dec 31, 2017 | -12.53% |
| Sep 30, 2017 | -13.70% |
| Jun 30, 2017 | -19.69% |
| Mar 31, 2017 | 57.07% |
| Dec 31, 2016 | 13.64% |
| Sep 30, 2016 | 71.36% |
| Jun 30, 2016 | -60.36% |
| Mar 31, 2016 | 54.27% |
| Dec 31, 2015 | 14.68% |
| Sep 30, 2015 | 90.98% |
| Jun 30, 2015 | -3.94% |
| Mar 31, 2015 | -56.68% |
| Dec 31, 2014 | -4.81% |
| Sep 30, 2014 | 208.00% |
| Dec 31, 2013 | -6.13% |